CeriBell, Inc.

CBLL·NasdaqGS·Healthcare
Compare
25.26+1.63 (+6.90%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours25.40+0.14 (+0.55%)Oct 12, 4:42 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close23.63
Open23.77
Day range23.2725.27
52-week range10.8525.63
Off day high−0.04%
Off 52-week high−1.43%
Volume696.84K
Avg. volume (3M)372.29K
Market cap969.43M
EPS (TTM)-1.76
Forward P/E-15.66
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.93
Shares outstanding38.38M
Short interest8.06% of float
Earnings dateAug 10, 2026 (est.)
Analyst target28.57
Profit margin−64.73%

Against its peers

Compare in full ›
CBLL NPCE BWAY IRTC ELMD CERS
Market cap 969.43M 446.22M 461.30M 3.52B 232.95M 455.45M
P/E (TTM) — — 49.8 — 21.6 —
Forward P/E -15.7 -59.8 22.6 83.2 46.1 -452.0
Price/book 7.5 37.5 5.8 18.9 4.4 6.5
Dividend yield — — — — — —
1-year change +97.25% +20.90% +55.28% −39.84% +12.79% +47.44%
Today +6.90% +2.60% −2.63% −0.02% +1.52% −1.74%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All CBLL news ›
TradingView·Positive

TD Cowen maintains Buy rating on CeriBell, $33 price target

TD Cowen maintained their Buy rating on CeriBell's stock with a price target of $33.00. The price target implies an upside of 39.8% from the Oct 1 close of $23.61. Key takeaways from the analyst note Strong Growth Potential: CeriBell's…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.